| Literature DB >> 24880671 |
Hiroyuki Koami1, Tsutomu Isa, Tomonari Ishimine, Shinichiro Kameyama, Toshinobu Matsumura, Kosuke Chris Yamada, Yuichiro Sakamoto.
Abstract
PURPOSE: To evaluate the risk factors for bowel necrosis in adult patients with hepatic portal venous gas (HPVG).Entities:
Mesh:
Substances:
Year: 2014 PMID: 24880671 PMCID: PMC4293455 DOI: 10.1007/s00595-014-0941-1
Source DB: PubMed Journal: Surg Today ISSN: 0941-1291 Impact factor: 2.549
Fig. 1Multi-detector computed tomography (MDCT) findings of the patients with hepatic portal venous gas (HPVG)
Fig. 2Study design. Thirty-three patients were divided into two groups based on the presence of bowel necrosis/ischemia
Baseline clinical characteristics
| Necrotic group ( | Non-necrotic group ( |
| |
|---|---|---|---|
| Clinical demographics | |||
| Age | 73.8 ± 9.2 | 77.4 ± 12.1 | 0.355† |
| Male | 8 (57.1 %) | 11 (57.9 %) | 0.966 |
| Admission | 9 (64.3 %) | 8 (42.1 %) | 0.208 |
| Abdominal pain | 9/10 (90.0 %) | 4/13 (30.8 %) | 0.006 |
| Vomit | 8/13 (61.5 %) | 8 (42.1 %) | 0.280 |
| Peritoneal signs | 7/13 (53.8 %) | 3/18 (16.7 %) | 0.036 |
| Shock | 8 (57.1 %) | 5 (26.3 %) | 0.073 |
| Systolic BP (mmHg) | 91.5 ± 30.3 | 112.4 ± 27.3 | 0.047† |
| HR (/min) | 117.5 ± 30.0 | 103.0 ± 32.0 | 0.161‡ |
| BT (°C) | 36.8 ± 1.4 | 36.8 ± 1.1 | 0.947† |
| RR (/min) | 24.5 ± 9.3 | 24.0 ± 10.0 | 0.442‡ |
| Laboratory data | |||
| WBC (/μL) | 15150 ± 12050 | 13200 ± 9400 | 0.122‡ |
| CRP (mg/dL) | 12.7 ± 10.8 | 7.6 ± 12.2 | 0.110‡ |
| pH | 7.37 ± 0.14 | 7.40 ± 0.21 | 0.781‡ |
| BE | −4.2 ± 8.10 | −1.3 ± 10.18 | 0.430† |
| T-BiL (mg/dL) | 0.7 ± 1.0 | 0.6 ± 0.6 | 0.567‡ |
| AST (U/L) | 82.5 ± 289.0 | 31.0 ± 24.0 | 0.012‡ |
| ALT (U/L) | 52.5 ± 68.0 | 20.0 ± 22.0 | 0.038‡ |
| CK (U/L) | 81.0 ± 833.5 | 65.0 ± 56.5 | 0.286‡ |
| LDH (U/L) | 454.5 ± 469.5 | 232.0 ± 115.0 | 0.019‡ |
| MDCT findings | |||
| Ascites | 8 (57.1 %) | 11 (57.9 %) | 0.622 |
| Free air | 0 (0.0 %) | 2 (10.5 %) | 0.324 |
| Gastroduodenal dilatation | 11 (78.6 %) | 10 (52.6 %) | 0.126 |
| Small intestinal dilatation | 13 (92.9 %) | 11 (57.9 %) | 0.030 |
| Large intestinal dilatation | 9 (64.3 %) | 11 (57.9 %) | 0.710 |
| Poor enhancement of the bowel wall | 7/9 (77.8 %) | 2/11 (18.2 %) | 0.012 |
| Intestinal pneumatosis | 13 (92.9 %) | 11 (57.9 %) | 0.030 |
| Mesenteric pneumatosis | 11 (78.6 %) | 9 (47.4 %) | 0.070 |
| Gas in the portal vein | 10 (71.4 %) | 8 (42.1 %) | 0.095 |
| Treatment and outcome | |||
| Operation performed | 8 (57.1 %) | 3 (15.8 %) | 0.017 |
| Dead | 10 (71.4 %) | 7 (36.8 %) | 0.049 |
BP Blood pressure, HR heart rate, BT body temperature, RR respiratory rate, WBC white blood cell, CRP c-reactive protein, BE base excess, T-Bil total-bilirubin, AST aspartate aminotransferase, ALT alanine aminotransferase, CK creatine kinase, LDH lactate dehydrogenase, MDCT multi-detector CT
† Mean ± standard deviation (t test)
‡ Median ± interquartile range (Mann–Whitney test)
Logistic regression analysis for predicting bowel necrosis
| Partial regression coefficient |
| Odds ratio | 95 % CI | |
|---|---|---|---|---|
| Systolic BP | −0.037 | 0.048 | 0.964 | (0.929–1.000) |
| LDH | 0.007 | 0.022 | 1.007 | (1.001–1.014) |
| Intestinal pneumatosis | 3.632 | 0.038 | 37.793 | (1.229–1162.062) |
| Constant | −1.906 | 0.461 |
CI confidence interval, BP blood pressure, LDH lactate dehydrogenase
Fig. 3Receiver-operating characteristic (ROC) curves for detecting bowel necrosis according to systolic blood pressure (BP) (a) and lactate dehydrogenase (LDH) (b). ROC receiver-operating characteristic, AUC area under the curve, BP blood pressure, LDH lactate dehydrogenase
Fig. 4Number of abnormal parameters in the two groups (a). New diagnostic criteria for bowel necrosis in the patients with hepatic portal venous gas (HPVG) (b). According to our criteria, positive bowel necrosis was defined by more than two abnormal findings. The sensitivity was 100 %, the specificity was 78.9 % and the accuracy was 87.9 %. HPVG hepatic portal venous gas, BP blood pressure, LDH lactate dehydrogenase